	Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment. J Neurol Waskowiak PT, de Jong BA, Uitdehaag BMJ, Myronenko A, Hulst HE, Klein M, Don´t be late! consortium. PMID: 41191127 [PubMed - in process]
	Benign multiple sclerosis and long-term outcomes after 30Â years. J Neurol Matas E, Bau L, Romero-Pinel L, León I, Arroyo-Pereiro P, Muñoz-Vendrell A, Martínez-Yélamos A, Martínez-Yélamos S. PMID: 41191123 [PubMed - indexed for MEDLINE]
	Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial. Mult Scler Selmaj KW, Steinman L, Comi G, Bar-Or A, Arnold DL, Hartung HP, Montalbán X, Havrdová EK, Sheffield JK, Krakovich A, Cheng CY, Riolo JV, Pachai C, Thorpe A, DeBoer E, Kappos L, Cohen JA, Cree BA. PMID: 41190505 [PubMed - indexed for MEDLINE]
	Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity. Mult Scler Sandgren S, Maceski AM, Benkert P, Einsiedler M, Schaedelin S, Oechtering J, Achtnichts L, Lalive PH, Müller S, Pot C, Heslegrave A, Hunt D, Lycke J, Hoepner R, Roth P, Gobbi C, Comabella M, Derfuss T, Kappos L, Granziera C, Abdelhak A, Leppert D, Willemse EA, Zetterberg H, Kuhle J. PMID: 41190504 [PubMed - indexed for MEDLINE]
	Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis. Front Immunol López-Molina M, Torres Iglesias G, Sáenz de Santa María-Diez G, Valentín-Quiroga J, Laso-García F, Gallego R, Pozo-Novoa J, Chamorro B, López-Collazo E, Puertas I, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L. PMID: 41190076 [PubMed - indexed for MEDLINE]
	Entertainment activities and the risk of multiple sclerosis: A Mendelian randomization analysis. Medicine (Baltimore) Wang Z, Wu W. PMID: 41189227 [PubMed - indexed for MEDLINE]
	Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapies. Medicine (Baltimore) Berkovich R, Greene N, Reddy SR, Chang E, Tarbox MH, Fadaee S, Quach C, Pyatkevich Y. PMID: 41189204 [PubMed - indexed for MEDLINE]
	Platelets During Myelin Repair in Multiple Sclerosis: Friend or Foe? J Neurochem Rivera FJ, Philp AR, Reyes CR, Valenzuela-Krugmann C, Silva ME. PMID: 41185454 [PubMed - indexed for MEDLINE]
	The periodontal pathogen Fusobacterium nucleatum is associated with disease severity in multiple sclerosis. Sci Rep Naito H, Nakamori M, Nishi H, Toko M, Muguruma T, Yamada H, Sugimoto T, Yamazaki Y, Ochi K, Kawaguchi H, Maruyama H. PMID: 41184431 [PubMed - indexed for MEDLINE]
	Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy. Neurol Neuroimmunol Neuroinflamm Nistri R, De Meo E, Kim NN, Pozzilli V, Goebl P, Sa M, Ramdas S, Parida A, Wright S, Wassmer E, Eyre M, Lim M, Rossor T, Hemingway C, Biswas A, Sudhakar S, Mankad K, Eshaghi A, Barkhof F, Ciccarelli O, Hacohen Y. PMID: 41183274 [PubMed - indexed for MEDLINE]
	Optimized Kappa-Index Test Protocol to Detect Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis. Eur J Neurol Björklund J, Itkonen O, Nokelainen P, Siuko M, Österlund-Tauriala E, Tienari PJ, Anttonen M. PMID: 41181945 [PubMed - indexed for MEDLINE]
	Hypogammaglobulinemia and infection rates in patients with multiple sclerosis treated with ocrelizumab for up to six years: A real-world single-center study. Mult Scler J Exp Transl Clin Khatri B, Van Zealand P, Tarima S, Schutten S, Baker A, Perea T. PMID: 41180904 [PubMed]
	Safety reporting quality in multiple sclerosis clinical trials: A review of phase III clinical trials included in FDA approval of disease-modifying treatments. Mult Scler J Exp Transl Clin Lin WZ, Lee JJ, Chertcoff A, Tremlett H, Kramer JLK. PMID: 41180903 [PubMed]
	The effect of balance training with stroboscopic glasses on postural stability and activity level in patients: a meta-analysis. Afr Health Sci Demir OB, Bilgin A. PMID: 41179548 [PubMed - indexed for MEDLINE]
	Dysregulation of the endocannabinoid system - a key factor in the progression of multiple sclerosis? J Med Life Paraschiv AC, V, Marge C, V. PMID: 41178906 [PubMed - indexed for MEDLINE]
	CAR T cells for multiple sclerosis: Engineering T cells to disrupt chronic B cell-driven neuroinflammation. Mult Scler Relat Disord Ortuño-Sahagún D, Hermosillo-Abundis C, Reyes-Mata MP, Arias Carrión Ó. PMID: 41176941 [PubMed - as supplied by publisher]
	Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. Mult Scler Relat Disord Karimi P, Pan C, Chirieac M, Blumentals WA. PMID: 41175531 [PubMed - as supplied by publisher]
	A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors. Mult Scler Relat Disord Sawicka KM, Feldman BM, Banwell B, Beyene J, Cragg JJ, Bar-Or A, Finlayson M, Guenette M, Lynd L, Raufdeen F, Toulany A, Traboulsee A, Yeh EA, Oh J. PMID: 41175530 [PubMed - as supplied by publisher]
	Genetically reduced MTHFR activity confers protection against multiple sclerosis. J Neuroimmunol Daghlas I, Pluvinage JV, Gill D. PMID: 41175453 [PubMed - as supplied by publisher]
	The impact of multiple sclerosis on parenting: a mixed-method systematic review. Disabil Rehabil Scallan Dowd E, O'Keeffe F. PMID: 41174823 [PubMed - as supplied by publisher]

Articles 1 - 20 / 42466

Page 1 of 2124



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy